Literature DB >> 11925386

Cumulative delivery rates after ICSI in women aged >37 years.

Kaan Osmanagaoglu1, Herman Tournaye, Efstratios Kolibianakis, Michel Camus, Andre Van Steirteghem, Paul Devroey.   

Abstract

BACKGROUND: Female patients aged >37 years have a poor prognosis after ICSI. To determine the cumulative delivery rates in these women by life-table analysis, 228 patients aged >37 years who had undergone a total of 437 ICSI cycles were analysed retrospectively.
METHODS: Only cycles in which fresh ejaculated sperm was used, and in which at least one oocyte was micro-injected, were analysed. The main outcome measure was cumulative rate of deliveries. Any delivery after 25 weeks gestation was included in the study.
RESULTS: In women aged 38-39 years, the real cumulative delivery rate after two cycles was 21%, while the expected delivery rate was 26%. In patients aged 40-43 years, the real and expected cumulative delivery rates were 12 and 17% respectively after three cycles, when they reached a plateau. There was only one delivery in the age group >43 years, which consisted of 26 patients with 66 cycles. In women aged >37 years, an expected cumulative delivery rate of 30% may be obtained at the end of the fourth cycle. Women aged >43 years do not have a realistic chance of achieving a delivery with their own oocytes.
CONCLUSIONS: This life-table analysis provides a means by which to counsel couples about their chances of achieving a delivery by ICSI at an age >37 years.

Entities:  

Mesh:

Year:  2002        PMID: 11925386     DOI: 10.1093/humrep/17.4.940

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Pronuclear and morphological features as a cumulative score to select embryos in ICSI (intracytoplasmic sperm injection) cycles according to sperm origin.

Authors:  Lia Mara Rossi-Ferragut; Assumpto Iaconelli; Tsutomu Aoki; Claudia Chagas Rocha; Daniela Regina dos Santos; Fábio Firmbach Pasqualotto; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2003-01       Impact factor: 3.412

Review 2.  Male factor infertility and ART.

Authors:  Herman Tournaye
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

3.  The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract.

Authors:  Willem Verpoest; Sara Seneca; Marjan De Rademaeker; Karen Sermon; Martine De Rycke; Michel De Vos; Patrick Haentjens; Paul Devroey; Ingeborg Liebaers
Journal:  J Assist Reprod Genet       Date:  2010-03-11       Impact factor: 3.412

4.  Too old for IVF: are we discriminating against older women?

Authors:  Norbert Gleicher; Andrea Weghofer; David Barad
Journal:  J Assist Reprod Genet       Date:  2007-12-04       Impact factor: 3.412

5.  Assisted reproduction counseling in women aged 40 and above: a cohort study.

Authors:  Michaël De Brucker; Herman Tournaye; Patrick Haentjens; Greta Verheyen; John Collins; Michel Camus
Journal:  J Assist Reprod Genet       Date:  2013-08-28       Impact factor: 3.412

6.  Prevalence of Thyroid Autoimmunity in Women with Recurrent Pregnancy Loss.

Authors:  Myrna Souraye Godines-Enriquez; Silvia Miranda-Velásquez; María Magdalena Enríquez-Pérez; Lidia Arce-Sánchez; Nayeli Martínez-Cruz; Claudia Montserrat Flores-Robles; Patricia Aguayo-González; Fela Vanessa Morales-Hernández; Alma Villarreal-Barranca; Blanca Vianey Suárez-Rico; Araceli Montoya-Estrada; José Romo-Yáñez; Enrique Reyes-Muñoz
Journal:  Medicina (Kaunas)       Date:  2021-01-22       Impact factor: 2.430

Review 7.  Microsurgical Management of Male Infertility: Compelling Evidence That Collaboration with Qualified Male Reproductive Urologists Enhances Assisted Reproductive Technology (ART) Outcomes.

Authors:  Jessica Marinaro; Marc Goldstein
Journal:  J Clin Med       Date:  2022-08-06       Impact factor: 4.964

8.  Treatment of recurrent pregnancy loss by Levothyroxine in women with high Anti-TPO antibody.

Authors:  Mohammad Hosein Mosaddegh; Nasrin Ghasemi; Tahere Jahaninejad; Fatemeh Mohsenifar; Abbas Aflatoonian
Journal:  Iran J Reprod Med       Date:  2012-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.